Aalborg University Hospital
Aalborg University Hospital
Aalborg, Denmark2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 3 | 2026-09-25 | NCT05083169 | |
| MDR - Comprehensive Primary Revision Stems PMCF | Arthralgia, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Shoulder Fractures, Shoulder Injuries, Shoulder Pain, Signs and Symptoms, arthropathy, bone fracture, injury, musculoskeletal system disorder | Enrolling by invitation | Not stated | 2026-07-09 | NCT06788717 |